Your browser doesn't support javascript.
loading
Efficacy and safety of mexiletine in non-dystrophic myotonias: A randomised, double-blind, placebo-controlled, cross-over study.
Vicart, Savine; Franques, Jérôme; Bouhour, Françoise; Magot, Armelle; Péréon, Yann; Sacconi, Sabrina; Nadaj-Pakleza, Aleksandra; Behin, Anthony; Zahr, Noël; Hézode, Marianne; Fournier, Emmanuel; Payan, Christine; Lacomblez, Lucette; Fontaine, Bertrand.
Afiliación
  • Vicart S; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, INSERM, Service of Neuro-Myology, Muscle Channelopathies Reference Center and UMR 974, Institute of Myology, University Hospital Pitié-Salpêtrière, Paris, France. Electronic address: savine.vicart@aphp.fr.
  • Franques J; Assistance Publique-Hôpitaux de Marseille, Department of Neurology and Neuromuscular Diseases, La Timone Hospital, Marseille, France.
  • Bouhour F; Electroneuromyography and Neuromuscular Disorders Department, Hospices Civils de Lyon, University Hospital of Lyon, France.
  • Magot A; Reference Centre for Neuromuscular disorders AOC, University Hospital, Hôtel-Dieu, Nantes, France.
  • Péréon Y; Reference Centre for Neuromuscular disorders AOC, University Hospital, Hôtel-Dieu, Nantes, France.
  • Sacconi S; Université Côte d'Azur, Peripheral Nervous System & Muscle Department, Pasteur 2 Hospital, Centre Hospitalier Universitaire de Nice, Nice, France.
  • Nadaj-Pakleza A; Reference Centre for Neuromuscular disorders AOC, Neurology Department, University Hospital of Angers, Angers, France.
  • Behin A; Assistance Publique-Hôpitaux de Paris, Service of Neuro-Myology, Reference Centre for Neuromuscular disorders NEIdF, University Hospital Pitié-Salpêtrière, Paris, France.
  • Zahr N; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Pharmacology Department, University Hospital Pitié-Salpêtrière, Paris, France.
  • Hézode M; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Department of Clinical Neurophysiology, University Hospital Pitié-Salpêtrière, Paris, France.
  • Fournier E; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Department of Clinical Neurophysiology, University Hospital Pitié-Salpêtrière, Paris, France.
  • Payan C; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Pharmacology Department, University Hospital Pitié-Salpêtrière, Paris, France.
  • Lacomblez L; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Pharmacology Department, University Hospital Pitié-Salpêtrière, Paris, France; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, INSERM U 1422, Neurology Department, University Hospital Pitié-Salpêtrière, Paris, France.
  • Fontaine B; Assistance Publique-Hôpitaux de Paris, Sorbonne Université, INSERM, Service of Neuro-Myology, Muscle Channelopathies Reference Center and UMR 974, Institute of Myology, University Hospital Pitié-Salpêtrière, Paris, France.
Neuromuscul Disord ; 31(11): 1124-1135, 2021 11.
Article en En | MEDLINE | ID: mdl-34702654
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mexiletine / Miotonía Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuromuscul Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Mexiletine / Miotonía Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Neuromuscul Disord Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article